A Deutsche Bank survey is asking investors what they're looking for on July 9, when a pause on the so-called reciprocal ...

BrightView Holdings shares declined 8.8% in premarket trading following lowered guidance for fiscal 2025. Shares were trading around $15.37. The stock is up 5.4% on the year.

CytoSorbents plans to ask Canadian health authorities to reconsider rejecting the company's license application for DrugSorb-ATR, an investigational device designed to reduce the severity of bleeding ...

Organon will discontinue its OG-6219 clinical-development program, after the investigational candidate failed to meet its primary efficacy endpoint in treating endometriosis-related pain.

Paramount bought and cancelled about 5.67 million shares under its current buyback program, which authorized it to repurchase up to 7.89 million shares through July 7. The natural gas producer's ...